학술논문
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
Document Type
Article
Author
Source
In Annals of Oncology September 2021 32(9):1127-1136
Subject
Language
ISSN
0923-7534